Developing an end to end bio-manufacturing platform for the new paradigm of SAM (Self Amplifying mRNA vaccines)

被引:0
|
作者
Roy, Varnika [1 ]
Bugno, Marcin [1 ]
Chinchilla-Olszar, Diana [1 ]
Forney-Stevens, Kelly [1 ]
Xie, Min [1 ]
Harrington, Laura [1 ]
Baldwin, Chris [1 ]
Delahaye, Nicolas [2 ]
Ulmer, Jeffrey [2 ]
Aggarwal, Kunal [1 ]
O'Hagan, Derek [1 ]
机构
[1] GSK, Vaccines Tech Res & Dev, Rockville, MD USA
[2] GSK, Vaccines Res & Dev, Rockville, MD USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
454
引用
收藏
页数:1
相关论文
共 3 条
  • [1] END -TO -END AUTOMATED MANUFACTURING OF AUTOLOGOUS CART CELL THERAPIES WITH THE NEW SEFIATM CELL THERAPY MANUFACTURING PLATFORM
    Reyes, C. Farino
    Jamal, R.
    Ryan, M.
    McKenzie, N.
    Mizzoni, C.
    Deshpande, S.
    Liu, Y.
    Maystrenko, A.
    Arab, D.
    Maggioni, M.
    Zotos, P.
    Zanoni, F.
    Parvizi, M.
    de Lageneste, M.
    Franchi, F.
    CYTOTHERAPY, 2024, 26 (06) : S166 - S167
  • [2] HOLISTIC DETERMINATION FOR ONESELF: A NEW PARADIGM FOR SELF-DETERMINATION AT END OF LIFE
    Samanta, Jo
    Samanta, Ash
    CAMBRIDGE LAW JOURNAL, 2013, 72 (03): : 689 - 719
  • [3] Sam68 promotes self-renewal and glycolytic metabolism in mouse neural progenitor cells by modulating AIdh1a3 pre-mRNA 3′-end processing
    La Rosa, Piergiorgio
    Bielli, Pamela
    Compagnucci, Claudia
    Cesari, Eleonora
    Volpe, Elisabetta
    Vecchioli, Stefano Farioli
    Sette, Claudio
    eLife, 2016, 5